Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
13.50
-0.31 (-2.24%)
At close: Jul 20, 2026, 4:00 PM EDT
13.91
+0.41 (3.04%)
Pre-market: Jul 21, 2026, 4:04 AM EDT
Summit Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
265
Market Cap
10.48B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 705.00K | -1.10M | -61.03% |
| Dec 31, 2021 | 1.81M | 949.00K | 110.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioMarin Pharmaceutical | 3.24B |
| Halozyme Therapeutics | 1.51B |
| Bio-Techne | 1.21B |
| Corcept Therapeutics | 769.10M |
| Axsome Therapeutics | 708.24M |
| Arrowhead Pharmaceuticals | 622.01M |
| Krystal Biotech | 417.30M |
| Cytokinetics | 105.82M |
SMMT News
- 4 days ago - Summit Therapeutics to Host Second Quarter 2026 Financial Results & Operational Progress Call on July 23, 2026 - Business Wire
- 6 days ago - Summit Therapeutics signs agreement to sell ridinilazole to Biossil - TheFly
- 6 days ago - Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc. - Business Wire
- 5 weeks ago - Summit Therapeutics withdraws proposed underwritten public offering - TheFly
- 5 weeks ago - Summit Therapeutics falls -10.2% - TheFly
- 5 weeks ago - Summit Therapeutics put volume heavy and directionally bearish - TheFly
- 5 weeks ago - Summit Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Summit Therapeutics announces $500M common stock offering - TheFly